Letko, Brosseau & Associates Inc Bausch Health Companies Inc. Transaction History

Letko, Brosseau & Associates Inc

  • $5.37 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$7.06 - $23.63 $2.19 Million - $7.32 Million
309,700 Added 23.09%
1,651,100 $13.8 Million
Q1 2022

May 11, 2022
BUY
$21.6 - $27.79 $1.51 Million - $1.95 Million
70,075 Added 5.51%
1,341,400 $30.7 Million
Q4 2021

Feb 09, 2022
BUY
$23.0 - $29.01 $2.46 Million - $3.11 Million
107,125 Added 9.2%
1,271,325 $35.2 Million
Q3 2021

Nov 03, 2021
BUY
$25.04 - $30.06 $29.2 Million - $35 Million
1,164,200 New
1,164,200 $32.5 Million

Others Institutions Holding BHC

# of Institutions
255
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email